IL71617A - 3-(amino-1-carboxylalkyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid derivatives,method for producing them and pharmaceutical compositions containing them - Google Patents

3-(amino-1-carboxylalkyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid derivatives,method for producing them and pharmaceutical compositions containing them

Info

Publication number
IL71617A
IL71617A IL71617A IL7161784A IL71617A IL 71617 A IL71617 A IL 71617A IL 71617 A IL71617 A IL 71617A IL 7161784 A IL7161784 A IL 7161784A IL 71617 A IL71617 A IL 71617A
Authority
IL
Israel
Prior art keywords
amino
sup
carboxylalkyl
benzothiazepine
tetrahydro
Prior art date
Application number
IL71617A
Other languages
English (en)
Other versions
IL71617A0 (no
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1983/000127 external-priority patent/WO1984004306A1/ja
Priority claimed from PCT/JP1983/000342 external-priority patent/WO1985001730A1/ja
Priority claimed from PCT/JP1984/000119 external-priority patent/WO1985004402A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of IL71617A0 publication Critical patent/IL71617A0/xx
Publication of IL71617A publication Critical patent/IL71617A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL71617A 1983-04-22 1984-04-22 3-(amino-1-carboxylalkyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid derivatives,method for producing them and pharmaceutical compositions containing them IL71617A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP1983/000127 WO1984004306A1 (en) 1983-04-22 1983-04-22 Fused 7-membered ring compounds and process for their preparation
PCT/JP1983/000342 WO1985001730A1 (en) 1983-10-13 1983-10-13 Fused 7-membered ring compounds and process for their preparation
PCT/JP1984/000119 WO1985004402A1 (en) 1984-03-24 1984-03-24 Fused 7-membered ring compounds and process for their preparation

Publications (2)

Publication Number Publication Date
IL71617A0 IL71617A0 (no) 1984-07-31
IL71617A true IL71617A (en) 1988-05-31

Family

ID=27304084

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71617A IL71617A (en) 1983-04-22 1984-04-22 3-(amino-1-carboxylalkyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid derivatives,method for producing them and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US4564612A (no)
EP (1) EP0125056B1 (no)
KR (1) KR910007965B1 (no)
AT (1) ATE60061T1 (no)
AU (1) AU565188B2 (no)
CA (1) CA1209993A (no)
DE (1) DE3483920D1 (no)
ES (2) ES531740A0 (no)
FI (1) FI82455C (no)
GR (1) GR79905B (no)
HU (1) HU193008B (no)
IE (1) IE57599B1 (no)
IL (1) IL71617A (no)
NO (1) NO162235C (no)
NZ (1) NZ207915A (no)
PH (1) PH21294A (no)
PT (1) PT78454B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2143816A (en) * 1983-06-29 1985-02-20 Mitsui Toatsu Chemicals Benzothiazepine derivatives
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
US4512988A (en) * 1984-03-01 1985-04-23 E. R. Squibb & Sons, Inc. Acylamino oxo or hydroxy substituted alkylamino thiazines and thiazepines
IL74004A (en) * 1984-03-24 1991-12-15 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine derivatives,their production and pharmaceutical compositions containing them
EP0187037A3 (en) * 1984-12-21 1988-03-23 Takeda Chemical Industries, Ltd. Piperidine derivatives, their production and use
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
JPH0657707B2 (ja) * 1987-05-25 1994-08-03 吉富製薬株式会社 ピペリジン化合物
JPS6450872A (en) * 1987-08-21 1989-02-27 Tanabe Seiyaku Co Production of 1,5-benzothiazepine derivative
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5290927A (en) * 1988-03-01 1994-03-01 Ajinomoto Co., Inc. Process for preparing 2',3'-dideoxyadenosine
AT393998B (de) * 1990-02-16 1992-01-10 Troendle Peter Paul Buch
AU4282993A (en) * 1992-07-01 1994-01-31 Pfizer Inc. Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists
IL108633A (en) * 1993-02-15 1998-07-15 Wellcome Found History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them
ZA956647B (en) * 1994-08-10 1997-02-10 Wellcome Found Hypolipidaemic compounds.
FR2781483A1 (fr) * 1998-07-21 2000-01-28 Hoechst Marion Roussel Inc Derives de thioazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicament et compositions pharmaceutiques les renfermant
FR2807039A1 (fr) * 2000-03-31 2001-10-05 Adir NOUVEAU PROCEDE DE PREPARATION DE LA 11-AMINO-3-CHLORO-6,11- DIHYDRO-5,5-DIOXO-6-METHYL-DIBENZO[c,f][1,2]-THIAZEPINE ET APPLICATION A LA SYNTHESE DE LA TIANEPTINE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341519A (en) * 1965-04-28 1967-09-12 Squibb & Sons Inc Novel benzoxazines, benzothiazines, benzoxazepins and benzothiazepins
AU543804B2 (en) * 1980-10-31 1985-05-02 Takeda Chemical Industries Ltd. Amides having bicyclic substituents on nitrogen
EP0057998B1 (en) * 1981-01-23 1984-08-08 Takeda Chemical Industries, Ltd. Alicyclic compounds, their production and use
EP0068173B1 (en) * 1981-06-05 1984-09-26 Merck & Co. Inc. Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives, process for preparing and pharmceutical composition containing the same
GB2103614B (en) * 1981-08-11 1984-11-21 Ciba Geigy Ag Benzazepin-2-ones
JPS5829779A (ja) * 1981-08-17 1983-02-22 Nippon Iyakuhin Kogyo Kk N−アミノアルキル−1,5−ベンゾチアゼピン誘導体の製造法
US4477464A (en) * 1983-02-10 1984-10-16 Ciba-Geigy Corporation Hetero-benzazepine derivatives and their pharmaceutical use
US4460579A (en) * 1983-02-28 1984-07-17 E. R. Squibb & Sons, Inc. Thiazine and thiazepine containing compounds
GB2143816A (en) * 1983-06-29 1985-02-20 Mitsui Toatsu Chemicals Benzothiazepine derivatives

Also Published As

Publication number Publication date
FI82455B (fi) 1990-11-30
NZ207915A (en) 1986-10-08
PT78454A (en) 1984-05-01
ES544748A0 (es) 1986-07-16
FI82455C (fi) 1991-03-11
KR840008346A (ko) 1984-12-14
ES8609290A1 (es) 1986-07-16
ES8602699A1 (es) 1985-12-01
IE57599B1 (en) 1993-01-27
HU193008B (en) 1987-08-28
US4564612A (en) 1986-01-14
EP0125056A3 (en) 1986-04-16
KR910007965B1 (ko) 1991-10-04
EP0125056B1 (en) 1991-01-16
DE3483920D1 (de) 1991-02-21
AU565188B2 (en) 1987-09-10
EP0125056A2 (en) 1984-11-14
FI841590A (fi) 1984-10-23
IL71617A0 (no) 1984-07-31
AU2709284A (en) 1984-10-25
FI841590A0 (fi) 1984-04-19
NO841555L (no) 1984-10-23
IE840927L (en) 1984-10-22
NO162235B (no) 1989-08-21
ES531740A0 (es) 1985-12-01
NO162235C (no) 1989-11-29
ATE60061T1 (de) 1991-02-15
PH21294A (en) 1987-09-28
GR79905B (no) 1984-10-31
HUT34176A (en) 1985-02-28
CA1209993A (en) 1986-08-19
PT78454B (en) 1986-08-28

Similar Documents

Publication Publication Date Title
IL71617A (en) 3-(amino-1-carboxylalkyl)amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-acetic acid derivatives,method for producing them and pharmaceutical compositions containing them
IL72523A (en) 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
GR3005315T3 (no)
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
ES2000481A6 (es) Procecimiento de preparacion de nuevos derivados del dihidro-2,3 benzofurano
FI871445A0 (fi) Foerfarande foer framstaellning av nya spergualinderivat.
ES8801653A1 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina
ES8401760A1 (es) Un procedimiento para la preparacion de derivados de ciclohepteno.
ES8801635A1 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzoxazepina.
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales